Jump to content

Guerbet

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by All In All In (talk | contribs) at 06:53, 25 July 2022. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Guerbet (EuronextGBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent.[1]

In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters are located in Villepinte, a suburb of Paris and its shares are included in the CAC Small stock index.

In July 2015, Guerbet announced the takeover of Mallinckrodt's contrast media and application systems divisions. The acquisition was completed in November 2015.[citation needed]

References

  1. ^ "Corporate history". Guerbet Group website. Retrieved 8 January 2019.